Quantum Leap Healthcare Collaborative™ is a 501C(3) charitable organization integrating high-impact clinical research with patient care to improve and save lives.

PORTFOLIO

Learn more about our projects

I-SPY Trials

Developing new cancer treatments faster and for less

BreastCancerTrials.org

Personalized matching to breast cancer clinical trials

CTMatch

Customizing trial matching to other diseases

OneSource

Radically streamling collection and distribution of data

I-SPY COVID

Focusing on the Problem with an Important New Solution

Visit the I-SPY website for more information.

Latest News

April 28, 2021

Quantum Leap Concludes Cenicriviroc Unlikely to Reduce Recovery Time in I-SPY COVID Trial

April 27, 2021

Laura Esserman in conversation with Janet Woodcock, Acting Commissioner of the FDA, at CRAACO 2021

April 15, 2021

I-SPY COVID Trial by Quantum Leap Suggests Icatibant not Likely to Impact Critical COVID-19 Patients

April 28, 2021

Quantum Leap Concludes Cenicriviroc Unlikely to Reduce Recovery Time in I-SPY COVID Trial

August 7, 2019

KEYTRUDA’s Success in TNBC Validates I-SPY 2 Adaptive Approach to Phase II Trials

February 15, 2019

Esserman among bioscience leaders profiled in SF Business Times